LP3 Network Free Webinar - Veterinary Compounding, A Customized Approach

Download in electronic PDF format for $25



Search the Complete Journal Archives

Stability of 4-Aminopyridine and 3,4-Diaminopyridine Oral Capsules

Author(s):  Trissel Lawrence A, Xu Quanyun A, Zhang Yanping

Issue:  Mar/Apr 2002 - Dermatologic Compounding
View All Articles in Issue

Abstract:  The objective of this study was to evaluate the chemical stability of 4-aminopyridine 5-mg capsules and 3,4-diaminopyridine 5-mg capsules under a variety of storage conditions. Each of the two drug preparations was extemporaneously prepared in hard gelatin capsules; lactose and micronized silica gel were used as excipients. Samples were stored under three conditions: refrigeration at 4°C and protected from light for 6 months, protected from light at room temperature that ranged from 22°C to 24°C for 6 months, and at a temperature of 37°C and protected from light for 1 month.

Once each month, visual inspection of the capsules and their powder contents was performed to identify observable changes (color, texture, etc), and the weight of the capsule content was measured individually. Chemical stability was assessed initially and at monthly intervals by means of a stability-indicating high-pressure liquid chromatography (HPLC) analytical technique based on the determination of drug content.

No visible changes were observed in any of the samples under any of the storage conditions. The hard gelatin capsules remained clear and colorless, and the content of the capsules remained an off-white powder when viewed under normal fluorescent room light. Capsule content weight did not change during the study. Both 4-aminopyridine and 3,4-diaminopyridine exhibited excellent chemical stability under all study conditions. Little or no loss of drug content occurred in either product under refrigeration, at room temperature, and even at the elevated temperature of 37°C.

The oral 5-mg capsules of 4-aminopyridine and 3,4-diaminopyridine did not undergo decomposition or other adverse changes within 6 months at refrigerated or room temperature or within 1 month of storage at 37°C.

Related Keywords: 4-Aminopyridine, oral capsules, stability of, 3,4-Diaminopyridine, oral capsules, stability of

Related Categories: PEER-REVIEWED, STABILITIES, COMPATIBILITIES

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Stability of 4-Aminopyridine and 3,4-Diaminopyridine Oral Capsules Trissel Lawrence A, Xu Quanyun A, Zhang Yanping Mar/Apr 2002 155-157 Buy
Women's Oral Health: Is There a Hormonal Link? Preckshot John Jan/Feb 2004 10 Buy
The Basics of Compounding: Compounding Special Capsules Allen Loyd V Jr Jul/Aug 1999 291 Buy
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Schotik Debora Jan/Feb 2001 9 Buy
Stability of Oral Liquid Dosage Forms of Ethacrynic Acid Gupta Vishnu D, Ling Jie May/Jun 2001 232-233 Buy
Stability of Prednisone in Oral Mix Suspending Vehicle Friciu Mihaela, Plourde Kevin, Leclair Grégoire, Danapoulos Panagiota, Savji Taslim Jul/Aug 2015 337-339 Buy
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa Sep/Oct 2015 414-419 Buy
Basics of Compounding: Special Capsules Allen Loyd V Jr May/Jun 2016 209-214 Buy
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Nahata Milap C May/Jun 2016 247-249 Buy
Pediatric Compounding: Coloring Outside the Lines Preckshot John Jan/Feb 2001 6 Buy